CCND1 and breast cancer: In serum-stimulated liver cancer (HepG2, HuH7, and SK-Hep1) and breast cancer (MCF7) cells, knockdown of cyclin D1 led to decreased cell cycle progression (as measured by DNA synthesis) and diminished lactate production (Fig. S1).